Skip to main content

Grafa News and Videos — Page 963

Grafa Headlines

Latest

Grafa

AbbVie receives European Commission approval for MAVIRET in acute hepatitis C

AbbVie (NYSE:ABBV) said the European Commission has granted approval for its oral antiviral MAVIRET (glecaprevir/pibrentasvir) to treat acute hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older with compensated liver disease, with or without cirrhosis.

Read more: AbbVie receives European Commission approval for MAVIRET in acute hepatitis C

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift